JP2023512455A5 - - Google Patents

Info

Publication number
JP2023512455A5
JP2023512455A5 JP2022542684A JP2022542684A JP2023512455A5 JP 2023512455 A5 JP2023512455 A5 JP 2023512455A5 JP 2022542684 A JP2022542684 A JP 2022542684A JP 2022542684 A JP2022542684 A JP 2022542684A JP 2023512455 A5 JP2023512455 A5 JP 2023512455A5
Authority
JP
Japan
Prior art keywords
compound
compound according
optionally substituted
conjugate
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022542684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512455A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012846 external-priority patent/WO2021142377A2/en
Publication of JP2023512455A publication Critical patent/JP2023512455A/ja
Publication of JP2023512455A5 publication Critical patent/JP2023512455A5/ja
Priority to JP2026019480A priority Critical patent/JP2026090375A/ja
Withdrawn legal-status Critical Current

Links

JP2022542684A 2020-01-10 2021-01-08 細胞表面受容体結合化合物およびコンジュゲート Withdrawn JP2023512455A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026019480A JP2026090375A (ja) 2020-01-10 2026-02-09 細胞表面受容体結合化合物およびコンジュゲート

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US202062959882P 2020-01-10 2020-01-10
US202062959862P 2020-01-10 2020-01-10
US202062959877P 2020-01-10 2020-01-10
US62/959,862 2020-01-10
US62/959,882 2020-01-10
US62/959,877 2020-01-10
US202063043754P 2020-06-24 2020-06-24
US202063043749P 2020-06-24 2020-06-24
US202063043752P 2020-06-24 2020-06-24
US63/043,754 2020-06-24
US63/043,749 2020-06-24
US63/043,752 2020-06-24
PCT/US2021/012846 WO2021142377A2 (en) 2020-01-10 2021-01-08 Cell surface receptor binding compounds and conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026019480A Division JP2026090375A (ja) 2020-01-10 2026-02-09 細胞表面受容体結合化合物およびコンジュゲート

Publications (2)

Publication Number Publication Date
JP2023512455A JP2023512455A (ja) 2023-03-27
JP2023512455A5 true JP2023512455A5 (cg-RX-API-DMAC7.html) 2024-01-16

Family

ID=76788318

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542684A Withdrawn JP2023512455A (ja) 2020-01-10 2021-01-08 細胞表面受容体結合化合物およびコンジュゲート
JP2026019480A Pending JP2026090375A (ja) 2020-01-10 2026-02-09 細胞表面受容体結合化合物およびコンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026019480A Pending JP2026090375A (ja) 2020-01-10 2026-02-09 細胞表面受容体結合化合物およびコンジュゲート

Country Status (9)

Country Link
US (1) US20230158155A1 (cg-RX-API-DMAC7.html)
EP (1) EP4087584A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023512455A (cg-RX-API-DMAC7.html)
KR (1) KR20220144893A (cg-RX-API-DMAC7.html)
CN (1) CN115315263A (cg-RX-API-DMAC7.html)
AU (1) AU2021206280A1 (cg-RX-API-DMAC7.html)
CA (1) CA3167272A1 (cg-RX-API-DMAC7.html)
IL (1) IL294564A (cg-RX-API-DMAC7.html)
WO (1) WO2021142377A2 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12697391B2 (en) 2018-04-09 2026-08-04 Yale University Bi-functional molecules to degrade circulating proteins
US12485178B2 (en) 2018-04-09 2025-12-02 Yale University Bifunctional small molecules to target the selective degradation of circulating proteins
CA3134610A1 (en) 2018-04-09 2019-10-17 Yale University Bifunctional small molecules to target the selective degradation of circulating proteins
US20240342293A1 (en) * 2019-10-10 2024-10-17 Yale University Engineered antibodies as molecular degraders through cellular receptors
MX2022009419A (es) 2020-01-31 2022-08-25 Avilar Therapeutics Inc Compuestos de union al asgpr para la degradacion de proteinas extracelulares.
AU2022268925A1 (en) 2021-05-03 2023-11-16 Avilar Therapeutics, Inc. Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteins
JP2024524614A (ja) * 2021-07-14 2024-07-05 ライシア セラピューティクス, インコーポレイテッド Asgpr細胞表面受容体結合化合物及びコンジュゲート
CN117915956A (zh) * 2021-07-14 2024-04-19 利西亚治疗公司 M6pr细胞表面受体结合化合物和缀合物
WO2023028590A1 (en) * 2021-08-27 2023-03-02 Yale University Molecular degraders of extracellular proteins
WO2023028338A2 (en) * 2021-08-27 2023-03-02 Avilar Therapeutics, Inc. Mannose 6-phosphate or asgpr receptor binding compounds for the degradation of extracellular proteins
PL4293785T3 (pl) 2021-11-12 2026-05-25 Lg Energy Solution, Ltd. Niewodny roztwór elektrolitu do litowej baterii akumulatorowej oraz litowa bateria akumulatorowa zawierająca ten roztwór
FR3132634B1 (fr) * 2022-02-15 2025-04-25 Nanomedsyn Composés bifonctionnels ciblant le récepteur du mannose 6-phosphate cation-indépendant
WO2024155748A1 (en) 2023-01-18 2024-07-25 Lycia Therapeutics, Inc. M6pr binding compounds and conjugates
AU2024208960A1 (en) * 2023-01-18 2025-07-24 Lycia Therapeutics, Inc. Asgpr binding compounds and conjugates
EP4651904A1 (en) * 2023-01-18 2025-11-26 Lycia Therapeutics, Inc. Lysosomal targeting bifunctional molecules for degradation of autoantibodies
FR3146400B1 (fr) * 2023-03-07 2026-01-30 Nanomedsyn Conjugués ciblant le récepteur du mannose 6-phosphate cation-indépendant et le tissu osseux
CN116023273A (zh) * 2023-03-29 2023-04-28 思合基因(北京)生物科技有限公司 一种新型碳糖苷及其制备方法
CN116854754B (zh) 2023-09-01 2023-12-12 北京悦康科创医药科技股份有限公司 一种含有核糖环或其衍生结构的GalNAc化合物及其寡核苷酸缀合物
CN117924386B (zh) * 2023-12-22 2024-07-12 合肥综合性国家科学中心大健康研究院 Hpa1降解剂及其制备方法和用途
US12685782B2 (en) 2024-07-31 2026-07-21 Biohaven Therapeutics Ltd. Bifunctional degraders for the treatment of Graves' disease
WO2026120177A1 (en) 2024-12-06 2026-06-11 Ascendis Pharma A/S Novel long-acting degrader conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002950217A0 (en) * 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
EP2448600B1 (en) * 2009-07-03 2016-03-30 INSERM - Institut National de la Santé et de la Recherche Médicale Compounds targeting the cation-independent mannose 6-phosphate receptor

Similar Documents

Publication Publication Date Title
JP2024524613A5 (cg-RX-API-DMAC7.html)
JP2024524614A5 (cg-RX-API-DMAC7.html)
CA2677041C (en) Multimeric conjugate
CA3167272A1 (en) Cell surface receptor binding compounds and conjugates
US20080267877A1 (en) Peptide-based carrier devices for stellate cells
JP2022533215A5 (cg-RX-API-DMAC7.html)
WO2020145228A1 (ja) 配位子及びCEACAM5抗体Fabフラグメントからなる複合体
JP2013518841A (ja) 増殖及びタンパク質合成の細胞内ターゲッティングのためのポリアニオン性多価高分子
JP2024524613A (ja) M6pr細胞表面受容体結合化合物及びコンジュゲート
JP2023542295A5 (cg-RX-API-DMAC7.html)
WO2010055950A1 (ja) 癌間質の構成因子に対して特異的結合能を有する物質と抗腫瘍性化合物との複合体による新規の癌ターゲティング治療
AU2006270566A1 (en) Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes
JP2022554094A5 (cg-RX-API-DMAC7.html)
JP2023553421A5 (ja) 抗cea免疫複合体、及びその使用
US20020018751A1 (en) Cellular and serum protein anchors for diagnostic imaging
US20250144222A1 (en) Bifunctional Compounds Targeting the Cation-Independent Mannose 6- Phosphate Receptor
JP6956959B2 (ja) アルブミン−糖鎖複合体
KR20190139796A (ko) Cox2 과발현 질환 진단용 조성물 및 이의 스크리닝 방법
JP2012508231A (ja) 血管内造影剤
JP2009511543A (ja) ビオチン標識を含む抗凝固抗血栓二重阻害剤
RU2814073C2 (ru) КОМПЛЕКС, СОДЕРЖАЩИЙ Fab-ФРАГМЕНТ АНТИТЕЛА ПРОТИВ MUC1 ЧЕЛОВЕКА, ПЕПТИДНЫЙ ЛИНКЕР И/ИЛИ ЛИГАНД
EP3755381B1 (en) Optical imaging agents targeting inflammation
EP4703381A1 (en) Antibodies against icam-1 and applications thereof
EP4438653A1 (en) Four-branch type water soluble polymer for medical use
JP2025535871A (ja) Fc-長鎖脂肪酸鎖を含む超長作用型プラットフォーム